The role of HER2/neu, BCL2, p53 genes and proliferating cell nuclear protein as molecular prognostic parameters in localized prostate carcinoma.
Fonseca
Gilvan Neiva
GN
Universidade Federal de São Paulo and Hospital Sírio Libanês, São Paulo, Brazil.
Srougi
Miguel
M
Leite
Katia Ramos Moreira
KR
Nesrallah
Luciano João
LJ
Ortiz
Valdemar
V
D000328:Adult; D000368:Aged; D002277:Carcinoma / Q000737:chemistry / Q000235:genetics / Q000473:pathology*; D019254:Genes, bcl-2 / Q000235:genetics*; D016158:Genes, p53 / Q000235:genetics*; D006801:Humans; D007150:Immunohistochemistry; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D018809:Proliferating Cell Nuclear Antigen / Q000032:analysis* / Q000096:biosynthesis; D011446:Prospective Studies; D011471:Prostatic Neoplasms / Q000737:chemistry / Q000235:genetics* / Q000473:pathology*; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000235:genetics*
D018809:Proliferating Cell Nuclear Antigen; D018719:Erb-b2 Receptor Tyrosine Kinases